Recent progress in nanotechnology based ferroptotic therapies for clinical applications

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Nanotechnology

Background:

• Ferroptosis is a distinct programmed cell death pathway regulated by iron and reactive oxygen species.
• This cell death mechanism is implicated in various diseases, including cancer, neurodegenerative disorders, and organ failure.
• Ferroptotic inducers and inhibitors are emerging as therapeutic strategies for both cancerous and non-cancerous conditions.

Purpose of the Study:

• To review the latest advancements in ferroptosis-based therapies.
• To highlight the role of nanotechnology in developing ferroptotic agents for disease diagnosis and treatment.
• To discuss future opportunities and challenges in nano-ferroptosis research.

Main Methods:

• Review of current literature on ferroptosis, nanotechnology, and theranostics.
• Analysis of tailored ferroptotic nanoparticles and molecular probes.
• Discussion of the integration of nanotechnology for enhanced therapeutic and diagnostic capabilities.

Main Results:

• Nanotechnology integration offers advantages like enhanced targeting, stimuli-responsiveness, improved solubility, and theranostic capabilities for ferroptosis.
• Tailored ferroptotic nanoparticles and molecular probes show potential for accurate disease diagnosis and treatment.
• Combination therapies involving nanotechnology and ferroptosis hold significant clinical importance.

Conclusions:

• Ferroptosis-based therapies, particularly when combined with nanotechnology, represent a promising frontier for treating a wide range of diseases.
• Further research into rational design of nano-ferroptotic drugs and theranostic probes is crucial for clinical translation.
• This field offers significant opportunities for developing innovative diagnostic and therapeutic strategies.